Recalls / Class II
Class IID-0175-2023
Product
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4
- Affected lot / code info
- Lot #: 126451 Exp. 04/30/2023
Why it was recalled
Short Fill
Recalling firm
- Firm
- Nephron Sc Inc
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 4500 12th Street Ext, N/A, West Columbia, South Carolina 29172-3025
Distribution
- Quantity
- 387,000 vials
- Distribution pattern
- Nationwide within the United States including Puerto Rico. Guatamala
Timeline
- Recall initiated
- 2023-01-13
- FDA classified
- 2023-01-23
- Posted by FDA
- 2023-02-01
- Terminated
- 2024-10-11
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0175-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.